Basi Guriqbal S. 4
4 · Sarepta Therapeutics, Inc. · Filed Mar 7, 2018
Insider Transaction Report
Form 4
Basi Guriqbal S.
SVP, Chief Scientific Officer
Transactions
- Award
Stock option (right to buy)
2018-03-05+70,000→ 70,000 totalExercise: $71.45Exp: 2028-03-05→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]25% of the option granted vests and is exercisable on the first anniversary of the date of grant and 1/48th of the total granted option will vest and become exercisable on each monthly anniversary thereafter, such that the option will be fully vested and exercisable on the fourth anniversary of the date of grant.